Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

Paediatrics and International Child Health is a prominent journal published by Taylor & Francis Ltd, dedicated to advancing the field of pediatric medicine and addressing global child health issues. With an ISSN of 2046-9047 and E-ISSN of 2046-9055, the journal has established itself as a vital resource for researchers, practitioners, and students interested in the health and well-being of children worldwide. Covering a broad scope of topics in pediatrics, perinatology, and child health, it has achieved a commendable Q3 ranking in its field, with a Scopus rank of 121 out of 330, placing it within the 63rd percentile for its discipline. The journal operates under an open access policy, allowing for wider dissemination and accessibility of its content. Through rigorous research articles, reviews, and case studies, Paediatrics and International Child Health aims to contribute to evidence-based practice, policy, and advocacy in international child health, making it an essential tool for professionals dedicated to improving child health outcomes globally.

Travel Medicine and Infectious Disease is a premier peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of travel medicine and infectious disease research. With an impressive impact factor and a category ranking of Q1 in both Infectious Diseases and Public Health, Environmental and Occupational Health, this journal is recognized as a leading source of high-quality research and insights. Originating in 2003 and transitioning to an Open Access model in 2023, it aims to disseminate critical findings that enhance the understanding of health risks associated with travel, vaccination strategies, and infectious disease outbreaks. The journal’s Scopus rankings reflect its influence, with a rank of 7/665 in Public Health and 20/344 in Infectious Diseases. Researchers, healthcare professionals, and students will find this journal invaluable for staying informed on the latest trends and developments in travel-related health challenges.

Infectious Diseases of Poverty, published by BMC, is a leading open-access journal dedicated to addressing the critical intersection of infectious diseases and poverty. Since its inception in 2012, this influential journal has contributed significantly to the fields of public health, infectious diseases, and environmental health. With impressive rankings placing it in the top quartile (Q1) across multiple categories—including Infectious Diseases and Public Health, Environmental and Occupational Health—it stands as a vital resource for researchers and practitioners alike. The journal's commitment to accessibility ensures that high-quality research is available to a global audience, fostering collaboration and knowledge sharing. Based in the UK, Infectious Diseases of Poverty aims to publish innovative research that sheds light on the complexities of infectious diseases and their socio-economic determinants, ultimately working to improve health outcomes in vulnerable populations around the world. With its robust impact factor and esteemed standing within the academic community, this journal serves as an essential platform for advancing the understanding and management of infectious diseases related to poverty.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Journal of Transport & Health is a premier peer-reviewed journal published by ELSEVIER SCI LTD, focusing on the interdisciplinary nexus between transportation systems and public health outcomes. Established in 2013, this journal has rapidly ascended to prominence, earning a Q1 ranking in prestigious fields such as Health Policy, Public Health, and Safety Research as of 2023. With a special emphasis on understanding the complex interactions between transport environments and health, it caters to researchers, professionals, and students dedicated to advancing knowledge in these critical areas. The journal not only provides valuable insights into the impact of transportation on health but also addresses related topics in pollution and safety, reflected in its commendable Scopus rankings. Although not open access, the journal remains an essential resource for those seeking to influence policy and practice in transport and health, stimulating discourse and innovation in the field.

The Journal of Occupational Medicine and Toxicology, published by BMC, is a pivotal open access journal that has been at the forefront of advancing knowledge in the fields of workplace health, environmental safety, and toxicology since its inception in 2006. With a robust impact factor and a distinguished reputation, this journal occupies a significant position in academic rankings, including Q2 in Public Health and Occupational Health, and Q1 in both Safety Research and Toxicology for 2023. Renowned for its rigorous peer-review process, it serves as a vital resource for researchers, professionals, and students aiming to disseminate and access high-quality research and innovative practices in occupational health and toxicological studies. Based in the United Kingdom, the journal prioritizes global access to research, ensuring that critical information reaches a diverse audience, conducive to the advancement of public health and safety. As it converges towards 2024, the journal continues to lead discussions that shape policies and practices related to workforce environments, chemical exposure, and preventative strategies in health management.

Tropical Diseases Travel Medicine and Vaccines, published by SPRINGERNATURE, stands at the forefront of research in the fields of infectious diseases and public health, with an impressive impact factor that signifies its relevance and influence. Since its inception in 2015, this peer-reviewed journal has maintained an open access policy, ensuring that cutting-edge research on tropical diseases and travel medicine is readily available to researchers, professionals, and students worldwide. The journal currently ranks in the Q2 Quartile for both Infectious Diseases and Public Health, Environmental and Occupational Health, reflecting its substantial contribution to these critical areas of study. With a strong Scopus rank of #176 in Public Health and #138 in Infectious Diseases, it serves as a vital platform for innovative studies that advance understanding and response strategies related to tropical diseases. For its vast audience, Tropical Diseases Travel Medicine and Vaccines not only acts as a bridge connecting researchers with practical applications but also nurtures academic discourse essential for future advancements in global health.

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.